Larson Tina Marriott
Insider CIK 1856414 · RXRX President and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-11-15 | 2024-11-19 | 14,286 | $6.18 | $88.3K | 506,852 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-10-24 | 2024-10-28 | 6,000 | — | $0 | 452,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-10-24 | 2024-10-28 | 6,000 | $1.06 | $6.4K | 527,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-10-24 | 2024-10-28 | 6,000 | $6.31 | $37.9K | 521,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-09-26 | 2024-09-30 | 0 | — | $0 | 458,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-09-26 | 2024-09-30 | 6,000 | $1.06 | $6.4K | 527,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-09-26 | 2024-09-30 | 6,000 | $7.00 | $42.0K | 521,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-08-29 | 2024-09-03 | 6,000 | — | $0 | 464,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-08-29 | 2024-09-03 | 6,000 | $7.56 | $45.4K | 521,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-08-29 | 2024-09-03 | 6,000 | $1.06 | $6.4K | 527,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-08-15 | 2024-08-19 | 14,319 | $6.69 | $95.8K | 521,138 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-07-25 | 2024-07-29 | 6,000 | — | $0 | 470,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-07-25 | 2024-07-29 | 6,000 | $8.13 | $48.8K | 535,457 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-07-25 | 2024-07-29 | 6,000 | $1.06 | $6.4K | 541,457 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-06-27 | 2024-06-28 | 6,000 | — | $0 | 476,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-06-27 | 2024-06-28 | 6,000 | $7.22 | $43.3K | 535,457 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-06-27 | 2024-06-28 | 6,000 | $1.06 | $6.4K | 541,457 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-05-30 | 2024-06-03 | 0 | — | $0 | 482,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-05-30 | 2024-06-03 | 3,000 | $8.78 | $26.3K | 535,457 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-05-30 | 2024-06-03 | 3,000 | $1.06 | $3.2K | 538,457 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-05-15 | 2024-05-17 | 9,998 | $10.01 | $100.1K | 533,233 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-04-25 | 2024-04-29 | 3,000 | — | $0 | 485,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-04-25 | 2024-04-29 | 3,000 | $1.06 | $3.2K | 546,231 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-04-25 | 2024-04-29 | 3,000 | $7.67 | $23.0K | 543,231 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-03-21 | 2024-03-25 | 8,000 | — | $0 | 488,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-03-21 | 2024-03-25 | 7,390 | $10.70 | $79.1K | 640,592 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-03-21 | 2024-03-25 | 610 | $11.34 | $6.9K | 639,982 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-03-21 | 2024-03-25 | 8,000 | $1.06 | $8.5K | 647,982 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-02-22 | 2024-02-23 | 8,000 | — | $0 | 496,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-02-22 | 2024-02-23 | 8,000 | $14.90 | $119.2K | 639,982 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-02-22 | 2024-02-23 | 8,000 | $1.06 | $8.5K | 647,982 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-02-15 | 2024-02-16 | 5,379 | $12.43 | $66.9K | 639,982 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-02-09 | 2024-02-13 | 447,917 | — | $0 | 447,917 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-02-09 | 2024-02-13 | 9,655 | — | $0 | 424,203 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-02-09 | 2024-02-13 | 223,958 | — | $0 | 648,161 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-02-09 | 2024-02-13 | 2,800 | $10.09 | $28.3K | 645,361 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2024-01-25 | 2024-01-29 | 8,000 | — | $0 | 504,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-01-25 | 2024-01-29 | 8,000 | $10.35 | $82.8K | 414,548 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2024-01-25 | 2024-01-29 | 8,000 | $1.06 | $8.5K | 422,584 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-12-28 | 2024-01-02 | 8,000 | — | $0 | 512,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-12-28 | 2024-01-02 | 8,000 | $1.06 | $8.5K | 422,548 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-12-28 | 2024-01-02 | 8,000 | $10.58 | $84.6K | 414,548 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-11-16 | 2023-11-17 | 3,000 | — | $0 | 520,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-11-16 | 2023-11-17 | 3,000 | $1.06 | $3.2K | 416,404 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-11-16 | 2023-11-17 | 3,000 | $6.76 | $20.3K | 413,404 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2023-11-15 | 2023-11-17 | 5,378 | $7.18 | $38.6K | 413,404 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-10-26 | 2023-10-30 | 3,000 | — | $0 | 523,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-10-26 | 2023-10-30 | 3,000 | $5.63 | $16.9K | 418,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-10-26 | 2023-10-30 | 3,000 | $1.06 | $3.2K | 421,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-09-28 | 2023-10-02 | 3,000 | — | $0 | 526,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-09-28 | 2023-10-02 | 3,000 | $1.06 | $3.2K | 421,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-09-28 | 2023-10-02 | 3,000 | $7.72 | $23.2K | 418,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-08-24 | 2023-08-28 | 3,000 | — | $0 | 529,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-08-24 | 2023-08-28 | 3,000 | $1.06 | $3.2K | 421,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-28 | 2,937 | $8.64 | $25.4K | 418,845 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-28 | 63 | $9.45 | $595 | 418,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2023-08-15 | 2023-08-17 | 5,378 | $9.18 | $49.4K | 418,782 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-07-29 | 2023-07-28 | 8,000 | — | $0 | 532,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-27 | 2023-07-28 | 4,373 | $14.05 | $61.4K | 424,160 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-07-27 | 2023-07-28 | 8,000 | $1.06 | $8.5K | 432,160 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-27 | 2023-07-28 | 3,627 | $13.12 | $47.6K | 428,533 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-06-29 | 2023-07-03 | 3,000 | — | $0 | 540,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-06-29 | 2023-07-03 | 3,000 | $1.06 | $3.2K | 427,160 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-06-29 | 2023-07-03 | 3,000 | $7.49 | $22.5K | 424,160 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-05-31 | 2023-06-02 | 3,000 | — | $0 | 543,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-05-31 | 2023-06-02 | 3,000 | $1.06 | $3.2K | 427,160 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-05-31 | 2023-06-02 | 3,000 | $8.63 | $25.9K | 424,160 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2023-05-15 | 2023-05-17 | 5,415 | $5.60 | $30.3K | 422,429 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-02-23 | 2023-02-27 | 8,000 | — | $0 | 546,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-02-23 | 2023-02-27 | 8,000 | $1.06 | $8.5K | 435,844 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-02-23 | 2023-02-27 | 8,000 | $7.82 | $62.6K | 427,844 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 1,603 | $8.44 | $13.5K | 427,844 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-02-01 | 2023-02-03 | 434,122 | — | $0 | 434,122 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2023-02-01 | 2023-02-03 | 3,093 | $8.55 | $26.4K | 429,447 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-02-01 | 2023-02-03 | 217,061 | — | $0 | 422,808 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-02-01 | 2023-02-03 | 9,732 | — | $0 | 432,540 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2023-01-26 | 2023-01-27 | 8,000 | — | $0 | 554,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2023-01-26 | 2023-01-27 | 8,000 | $1.06 | $8.5K | 211,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-01-26 | 2023-01-27 | 8,000 | $8.07 | $64.6K | 203,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-12-29 | 2022-12-30 | 8,000 | — | $0 | 562,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-12-29 | 2022-12-30 | 8,000 | $1.06 | $8.5K | 211,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-12-29 | 2022-12-30 | 8,000 | $7.70 | $61.6K | 203,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-11-17 | 2022-11-17 | 16,000 | — | $0 | 570,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-11-17 | 2022-11-17 | 16,000 | $10.96 | $175.4K | 203,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-11-17 | 2022-11-17 | 16,000 | $1.06 | $17.0K | 219,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2022-11-15 | 2022-11-17 | 1,453 | $11.86 | $17.2K | 203,654 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-10-27 | 2022-10-28 | 16,000 | — | $0 | 586,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-10-27 | 2022-10-28 | 16,000 | $1.06 | $17.0K | 221,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-10-27 | 2022-10-28 | 16,000 | $10.72 | $171.5K | 205,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-09-29 | 2022-10-03 | 16,000 | — | $0 | 602,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 64 | $11.53 | $738 | 205,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 15,936 | $10.86 | $173.1K | 205,171 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-09-29 | 2022-10-03 | 16,000 | $1.06 | $17.0K | 221,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-08-16 | 2022-08-17 | 16,000 | — | $0 | 618,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-08-16 | 2022-08-17 | 16,000 | $12.60 | $201.6K | 295,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-08-16 | 2022-08-17 | 16,000 | $1.06 | $17.0K | 221,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2022-08-15 | 2022-08-17 | 1,453 | $12.96 | $18.8K | 205,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2022-05-16 | 2022-05-18 | 1,458 | $5.67 | $8.3K | 206,560 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-03-04 | 2022-03-08 | 58,500 | — | $0 | 634,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-03-04 | 2022-03-08 | 58,500 | $1.06 | $62.0K | 208,018 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-02-18 | 2022-02-22 | 16,000 | — | $0 | 692,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-02-18 | 2022-02-22 | 16,000 | $1.06 | $17.0K | 149,518 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-02-14 | 2022-02-17 | 4,000 | — | $0 | 708,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-02-14 | 2022-02-17 | 4,000 | $1.06 | $4.2K | 133,518 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-02-04 | 2022-02-08 | 4,784 | — | $0 | 4,784 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-02-04 | 2022-02-08 | 159,226 | — | $0 | 159,226 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-02-04 | 2022-02-08 | 2,392 | — | $0 | 130,346 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2022-02-04 | 2022-02-08 | 828 | $11.40 | $9.4K | 129,518 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-02-04 | 2022-02-08 | 79,613 | — | $0 | 127,954 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-16 | 2021-12-20 | 1,160 | $18.09 | $21.0K | 48,840 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-16 | 2021-12-20 | 300 | $19.78 | $5.9K | 47,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-16 | 2021-12-20 | 1,040 | $19.17 | $19.9K | 47,800 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-18 | 2021-11-22 | 702 | $19.20 | $13.5K | 50,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-18 | 2021-11-22 | 1,798 | $18.81 | $33.8K | 50,702 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 712,500 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 712,500 | — | $0 | 712,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 150,000 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 52,500 | — | $0 | 52,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 52,500 | — | $0 | 0 | SEC↗ |